Immunogenicity and safety of a novel MMR vaccine (live, freeze-dried) containing the Edmonston-Zagreb measles strain, the Hoshino mumps strain, and the RA 27/3 rubella strain: Results of a randomized, comparative, active controlled phase III clinical trial. [electronic resource]
Producer: 20180314Description: 1523-1530 p. digitalISSN:- 2164-554X
- Antibodies, Viral -- blood
- Drug-Related Side Effects and Adverse Reactions -- epidemiology
- Female
- Humans
- Immunoglobulin G -- blood
- Infant
- Male
- Measles virus -- immunology
- Measles-Mumps-Rubella Vaccine -- administration & dosage
- Mumps virus -- immunology
- Rubella virus -- immunology
- Vaccines, Attenuated -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.